NCT06859450View on ClinicalTrials.gov

Local Antibiotic Delivery for Community Acquired Pneumonia

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2028

Conditions
Community Acquired Pneumonia (CAP)
Interventions
DRUG

Levofloxacin

Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.

DRUG

Placebo

Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.

All Listed Sponsors
lead

Copenhagen Respiratory Research

NETWORK

NCT06859450 - Local Antibiotic Delivery for Community Acquired Pneumonia | Biotech Hunter | Biotech Hunter